Atlas Trials

Yong Fang

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Yong Fang

RecordFirmDate
A Retrospective Real-World Study on the Efficacy and Safety of Anlotinib Hydrochloride Combined With Immunotherapy Maintenance Therapy Following Standard Chemoimmunotherapy for ES-SCLC (ALTER-L059) (NCT06982287)Yong Fang2025-08-01
Anlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLC (NCT03726736)Yong Fang2018-12-21

Track Yong Fang automatically

Every clearance here is in the API, with alerts when new ones post.